# Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer

> **NCT00004144** · PHASE1 · COMPLETED · sponsor: **Barbara Ann Karmanos Cancer Institute** · enrollment: 36 (actual)

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** bryostatin 1
- **DRUG:** gemcitabine hydrochloride

## Key facts

- **NCT ID:** NCT00004144
- **Lead sponsor:** Barbara Ann Karmanos Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-05
- **Primary completion:** 2006-12
- **Final completion:** 2006-12
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2014-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004144, "Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00004144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*